<DOC>
	<DOCNO>NCT00003057</DOCNO>
	<brief_summary>RATIONALE : Drugs octreotide loperamide hydrochloride use different way relieve diarrhea cause chemotherapy . PURPOSE : Randomized phase III trial compare effectiveness octreotide loperamide hydrochloride treatment chemotherapy-related diarrhea patient colorectal cancer .</brief_summary>
	<brief_title>Octreotide Compared With Loperamide Hydrochloride Chemotherapy-Related Diarrhea Patients With Colorectal Cancer</brief_title>
	<detailed_description>OBJECTIVES : I . Determine safety efficacy octreotide acetate versus conventional therapy loperamide hydrochloride chemotherapy relate diarrhea patient advance colorectal malignancy undergo chemotherapy fluorouracil fluorouracil base regimen . OUTLINE : This prospective , randomize , parallel , open label , multicenter study . Patients stratify therapy , grade diarrhea , prior use loperamide hydrochloride octreotide acetate . Patients undergo 1 3 treatment . Patients receive either low dos octreotide ( arm A ) high dos octreotide ( arm B ) subcutaneously 3 time daily 5 day . Patients arm C receive oral dos loperamide follow unformed stool 5 day . A diary complete patient record medication bowel history . Treatment continue diarrhea persists beyond day 5 , consider treatment failure . If diarrhea continue worsen , patient remove study . All patient follow 24 day . PROJECTED ACCRUAL : This study accrue total 500 patient .</detailed_description>
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Diarrhea</mesh_term>
	<mesh_term>Octreotide</mesh_term>
	<mesh_term>Loperamide</mesh_term>
	<mesh_term>Antidiarrheals</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically confirm colorectal carcinoma At least grade 2 diarrhea consequence chemotherapy PATIENT CHARACTERISTICS : Age : 18 Performance status : ECOG 02 Life expectancy : Not specify Hematopoietic : Not specify Hepatic : Not specify Renal : Not specify Other : Concurrent enrollment SWOG9420 protocol allow No sensitivity octreotide acetate loperamide hydrochloride Eligible le 24 hour since prior loperamide octreotide resolution diarrhea Not pregnant lactate Effective contraception require fertile patient Not HIV positive No idiopathic ulcerative colitis Crohn 's disease , acute stool culture positive bacterial colitis , pseudomembranous colitis , short bowel syndrome , enteroenteric fistula , chronic pancreatitis , ischemic bowel disease , gastrointestinal disorder know cause diarrhea Absence definitive culture result require PRIOR CONCURRENT THERAPY : Biologic therapy : Not specify Chemotherapy : Prior chemotherapy fluoropyrimidine alone combination accept modulating agent ( leucovorin , levamisole , methotrexate , interferon , PALA , hydroxyurea ) require Prior chemotherapy uracil mustard tegafur ( UFT ) allow No concurrent chemotherapy allow study Endocrine therapy : Not specify Radiotherapy : No whole pelvic abdominal radiation therapy allow Surgery : No colectomy , coloanal anastamosis , abdominoperineal resection , colostomy allow Other : No antidiarrheal agent ( e.g. , diphenoxylate hydrochloride , elixir paregoric , opium tincture tincture belladonna , kaolin ) study No cyclosporine allow</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2009</verification_date>
	<keyword>colon cancer</keyword>
	<keyword>rectal cancer</keyword>
	<keyword>diarrhea</keyword>
</DOC>